Dermatology · Providence, RI
NPI
1013356567
Since 2013
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
593 Eddy St
Providence, RI, 02903
Phone (401) 444-7139
Groups this clinician bills Medicare through
Medicare paid, 2023
$352
12 services
Medicare patients, 2023
11
Average age 52
Drug cost, 2024
$834K
1,613 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Pooya Jahanshahi prescribed most often to Medicare patients was Clobetasol Propionate, with 276 prescriptions and refills. In total Pooya Jahanshahi wrote 1,613 Medicare prescriptions that cost $834K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Clobetasol Propionate Generic | 276 | 321 | 115 | $7,986 |
| Ketoconazole Generic | 223 | 232 | 86 | $3,410 |
| Fluocinonide Generic | 134 | 140 | 75 | $3,248 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 131 | 167 | 74 | $12K |
| Cosentyx Sensoready (2 Pens) Secukinumab | 77 | 77 | Under 11 | $374K |
| Triamcinolone Acetonide Generic | 76 | 97 | 47 | $1,940 |
| Tacrolimus Generic | 72 | 73 | 47 | $4,738 |
| Hydrocortisone Generic | 58 | 64 | 26 | $763 |
| Fluorouracil Generic | 43 | 43 | 33 | $1,668 |
| Retin-A Tretinoin | 41 | 41 | 17 | $1,354 |
| Metronidazole Generic | 41 | 41 | 23 | $797 |
| Doxycycline Monohydrate Generic | 41 | 46 | 22 | $974 |
| Alclometasone Dipropionate Generic | 41 | 64 | 33 | $2,569 |
| Econazole Nitrate Generic | 35 | 40 | 15 | $1,209 |
| Dupixent Pen Dupilumab | 34 | 34 | Under 11 | $124K |
Brand drugs: 211 claims; generic drugs: 1,402 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Pooya Jahanshahi were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.